Securities Code: 002432 Securities Abbreviation: Ninehealth Medical Announcement No.: 2026-030 Tianjin Ninehealth Medical Electronics Co., Ltd. Announcement Regarding the Adoption of the Independent Exercise Mode for the Fourth Exercise Period of the 2021 Stock Option Incentive Plan The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and are free from any false representations, misleading statements, or material omissions. Special Notes:
- The Company's stock option code is: 037205, and the option abbreviation is: Ninehealth JLC2.
- A total of 280 eligible participants in the fourth exercise period of the Company's 2021 Stock Option Incentive Plan meet the exercise conditions. The number of exercisable options is 1.37875 million, with an exercise price of ¥2.96 per option.
- This exercise adopts the independent exercise mode.
- The actual exercise period is from May 12, 2026, to May 3, 2027.
- If all exercisable stock options are exercised, the Company's shares will still meet the listing conditions. Tianjin Ninehealth Medical Electronics Co., Ltd. (hereinafter referred to as the "Company") held the Fourth Meeting of the Seventh Board of Directors on April 28, 2026, and deliberated and approved the "Proposal on the Achievement of Exercise Conditions for the Fourth Exercise Period of the 2021 Stock Option Incentive Plan." For details, please refer to the "Announcement on the Achievement of Exercise Conditions for the Fourth Exercise Period of the 2021 Stock Option Incentive Plan" (Announcement No.: 2026-020) published on the Juchao Information Network on April 29, 2026. As of the date of this announcement, the independent exercise matter has been reviewed and approved by the Shenzhen Stock Exchange, and the Company has completed the relevant registration and reporting work for independent exercise at the Shenzhen Branch of China Securities Depository and Clearing Corporation Limited. I. Explanation of the Achievement of Exercise Conditions for the Fourth Exercise Period of the Stock Options Granted Under the 2021 Stock Option Incentive Plan
- Waiting Period According to the "2021 Stock Option Incentive Plan (Second Revision Draft)," the stock options granted under this plan, after 16 months from the grant date, can be exercised by eligible participants in four installments within the following 48 months, provided that the exercise conditions are met. The exercise periods and the schedule for each installment are as follows:
| Exercise Arrangement | Exercise Period | Exercise Ratio |
|---|---|---|
| First exercise period of stock options | From the first trading day after 16 months from the grant date to the last trading day within 28 months from the grant date | 25% |
| Second exercise period of stock options | From the first trading day after 28 months from the grant date to the last trading day within 40 months from the grant date | 25% |
| Third exercise period of stock options | From the first trading day after 40 months from the grant date to the last trading day within 52 months from the grant date | 25% |
| Fourth exercise period of stock options | From the first trading day after 52 months from the grant date to the last trading day within 64 months from the grant date | 25% |